Histalim Overview

  • Founded
  • 2005
  • Status
  • Acquired/​Merged
  • Employees
  • 35
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Histalim General Information


Provider of histology, immunohistochemistry (IHC), In Situ Hybridization (ISH) and image analysis services. The company is engaged in development of new therapies in the domains of oncology and chronic diseases, including therapeutic antibody and new generation diagnostic tools. It also takes part in development projects for pharmaceutic products, medical devices and diagnostic tools.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Other Industries
Drug Delivery
Parent Company
Primary Office
  • 126 Rue Emile Baudot
  • 34000 Montpellier
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Histalim Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Histalim‘s full profile, request access.

Request a free trial

Histalim Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Provider of histology, immunohistochemistry (IHC), In Situ Hybridization (ISH) and image analysis services. The company
Montpellier, France
35 As of 2016

000000 0

elit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
Williamsville, NY
00 As of 0000
000000000 - 00.000


liqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea comm
Nether Alderley, United Kingdom
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Histalim Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Empire Genomics Venture Capital-Backed Williamsville, NY 00 00.000 000000000 - 00.000
0000000000 Corporate Backed or Acquired Nether Alderley, United Kingdom 00 000000&0
000000 000000000 Venture Capital-Backed Exton, PA 00 00.00 00000000000 00.00
00000000 0000 Corporate Backed or Acquired Boulder, CO 00 000000&0
000-00 000000000 0 Corporation Newcastle upon Tyne, United Kingdom
To view Histalim’s complete competitors history, request access »

Histalim Patents

Histalim Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2400279-A1 Method for colour grading of an optical microscope apparatus and device for implementing same Withdrawn 15-Jun-2010 00000000 0

Histalim Executive Team (1)

Name Title Board Seat Contact Info
Jean-Philippe Coton Managing Director & Publication Manager
To view Histalim’s complete executive team members history, request access »

Histalim Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial